Hikma updates on ANDA for generic Advair Diskus

22 September 2020 - Hikma Pharmaceuticals announces that it has received a minor complete response letter from the US FDA ...

Read more →

Medeor Therapeutics’ transplant immune tolerance therapy receives regenerative medicine advanced therapy designation from FDA

22 September 2020 - Medeor Therapeutics today announced that the U.S. FDA has granted a regenerative medicine advanced therapy designation ...

Read more →

U.S. FDA accepts for priority review Bristol Myers Squibb and bluebird bio application for anti-BCMA CAR T-cell therapy idecabtagene vicleucel (Ide-cel, bb2121)

22 September 2020 - Ide-cel is the first CAR T cell therapy accepted for regulatory review for multiple myeloma. ...

Read more →

FDA launches the Digital Health Center of Excellence

22 September 2020 - Today, the U.S. Food and Drug Administration announced it is launching the Digital Health Center of Excellence ...

Read more →

Gyroscope Therapeutics granted FDA fast track designation for GT005, an investigational gene therapy for dry age-related macular degeneration

22 September 2020 - Gyroscope Therapeutics today announced that the U.S. FDA has granted fast track designation to GT005 for the ...

Read more →

ADC Therapeutics submits biologics license application to the U.S. FDA for loncastuximab tesirine for treatment of relapsed or refractory diffuse large B-cell lymphoma

21 September 2020 - Submission based on efficacy and safety data from LOTIS 2 clinical trial. ...

Read more →

You can trust the FDA’s vaccine process

20 September 2020 - The agency can roll out a Covid shot safely, quickly and without bowing to political pressure. ...

Read more →

Crinetics Pharmaceuticals receives rare paediatric disease designation from FDA for CRN04777 for the treatment of congenital hyperinsulinism

21 September 2020 - Crinetics Pharmaceuticals today announced that the U.S. Food and Drug FDA has granted rare paediatric disease designation ...

Read more →

Democratic chairman says White House blocked FDA commissioner from testifying

19 September 2020 - The White House blocked FDA Commissioner Stephen Hahn from testifying before the House panel overseeing the ...

Read more →

Ardelyx announces FDA acceptance for filing of its new drug application of tenapanor for the control of serum phosphorus in adult patients with CKD on dialysis

15 September 2020 - New drug application supported by data from expansive clinical development program demonstrating tenapanor's use as foundational therapy. ...

Read more →

In ‘power grab,’ Health Secretary Azar asserts authority over FDA

19 September 2020 - Experts said the memo would make it more difficult for the F.D.A. to issue new rules, but ...

Read more →

US FDA grants once daily dosing option for Nityr (nitisinone) tablets for HT-1 patients

14 September 2020 - Cycle Pharmaceuticals is pleased to announce that the U.S. FDA has approved the once daily dosing ...

Read more →

Agenus initiates rolling BLA submission of balstilimab for recurrent/metastatic cervical cancer

18 September 2020 - Agenus announced the initiation of the rolling submission of its biologics license application to the U.S. FDA ...

Read more →

Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer

16 September 2020 - Next generation biomarker cytology test supports World Health Organization’s goal to eliminate cervical cancer, which is nearly ...

Read more →

ChemoCentryx announces FDA acceptance of the avacopan new drug application for the treatment of ANCA associated vasculitis

17 September 2020 - FDA sets PDUFA goal date of 7 July 2021. ...

Read more →